Invesco

Invesco’s Cullinan Oncology CGEM Stock Holding History

Invesco’s Portfolio CGEM Stock Details CGEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.47M	Buy	244,150 +113,827	+87%	+$1.46M	﹤0.01%	2324
2025 Q4	$1.35M	Buy	130,323 +28,011	+27%	+$253K	﹤0.01%	2780
2025 Q3	$607K	Buy	102,312 +41,757	+69%	+$306K	﹤0.01%	3157
2025 Q2	$456K	Buy	60,555 +11,312	+23%	+$90.9K	﹤0.01%	3196
2025 Q1	$373K	Sell	49,243 -10,310	-17%	-$98.9K	﹤0.01%	3276
2024 Q4	$725K	Buy	59,553 +1,395	+2%	+$20.1K	﹤0.01%	3053
2024 Q3	$974K	Buy	58,158 +8,797	+18%	+$156K	﹤0.01%	2916
2024 Q2	$861K	Buy	49,361 +1,954	+4%	+$41.6K	﹤0.01%	3009
2024 Q1	$808K	Buy	47,407 +36,784	+346%	+$568K	﹤0.01%	3092
2023 Q4	$108K	Buy	+10,623	New	+$94.1K	﹤0.01%	3676
2023 Q1	–	Sell	-10,057	Closed	-$106K	–	3883
2022 Q4	$106K	Sell	10,057 -76	-0.8%	-$923	﹤0.01%	3812
2022 Q3	$129K	Buy	10,133 +19	+0.2%	+$256	﹤0.01%	3788
2022 Q2	$129K	Sell	10,114 -1,720	-15%	-$19.5K	﹤0.01%	3839
2022 Q1	$124K	Buy	11,834 +203	+2%	+$2.74K	﹤0.01%	3848
2021 Q4	$180K	Buy	11,631 +2,504	+27%	+$49.9K	﹤0.01%	3807
2021 Q3	$205K	Buy	+9,127	New	+$244K	﹤0.01%	3793

Other funds holding CGEM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return